Jang-Ho Cha is the Chief Scientific and Medical Officer at Latus Bio, leading the development of gene therapies for neurodegenerative disorders. An MD/PhD from the University of Michigan, he has held senior roles at Novartis and Merck, focusing on translational neuroscience. People who have worked with him describe him as knowledgeable, decisive, and efficient.
His career is deeply intertwined with patient advocacy, particularly for Huntingtons disease (HD). He has served as the Chairman of the Board for the Huntingtons Disease Society of America, reflecting a profound commitment to unifying patients, families, and medical professionals to combat the disease and provide hope.
Unique fact: Dr. Cha was part of the scientific team that helped discover the HTT gene, the gene responsible for Huntingtons Disease.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.